BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Arbutus Presents HBV Data at 2017 AASLD Liver Meeting

  The presentations feature multiple Arbutus pipeline programs that highlight the potential of its product candidates and the breadth of its portfolio being advanced to improve current cure rates in chronic HBV.

  October 24, 2017

   · 

  12 min read
• BioMidwest

  SonarMed Completes $3M Series C Preferred Stock Financing

  Proceeds support ongoing controlled market roll-out and launch of the AirWave Monitoring System for pediatric patients.

  October 24, 2017

   · 

  2 min read
• Biotech Bay

  Global Blood Therapeutics Announces Approval of First-in-Class ‘Voxelotor’ as Nonproprietary Name for GBT440

  Voxelotor is an oral, once-daily therapy that is designed to modulate hemoglobin affinity for oxygen and is in clinical development for the treatment of sickle cell disease.

  October 24, 2017

   · 

  5 min read
• Business

  BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

  The Company has engaged Quintain Project Solutions LLC as the manufacturing project management leader for the PURE EP System.

  October 24, 2017

   · 

  4 min read
• Drug Development

  Cellectar Biosciences Introduces Multiple Dose Regimen in Fifth Cohort of Phase 1 Trial of CLR 131 in Multiple Myeloma

  In September, the trial’s Data Monitoring Committee (DMC) determined that the fourth cohort single dose of 31.25 mCi/m2 was safe and tolerated.

  October 24, 2017

   · 

  6 min read
• BioCapital

  K2M to Feature First FDA-Cleared 3D-Printed Expandable Interbody System, Industry-Leading 3D-Printed Portfolio, & Balance ACS Platform at NASS 2017

  Favorable data on K2M’s cervical spinal solutions to be presented during scientific sessions.

  October 24, 2017

   · 

  11 min read
• Policy

  Myriad Submits BRACAnalysis CDx Application for Regulatory Approval in Japan for HER2- Metastatic Breast Cancer

  Myriad estimates there are greater than 10,000 cases of HER2- metastatic breast cancer per year in Japan which would be eligible for testing with BRACAnalysis CDx.

  October 24, 2017

   · 

  6 min read
• Business

  Resverlogix Announces Right of First Refusal Agreement With Hepalink USA

  Hepalink paid $8 million (the “Fee”) to Resverlogix in consideration for the right of first refusal granted.

  October 24, 2017

   · 

  4 min read
• Policy

  ContraVir Pharmaceuticals Announces National Institutes of Health Funded Study on Antiviral Activity of CRV431

  ContraVir will utilize preclinical services from the NIAID to characterize the antiviral activity of CRV431 in a humanized mouse model of hepatitis B virus infection.

  October 24, 2017

   · 

  4 min read
• Business

  BioCryst to Announce Third Quarter 2017 Financial Results on November 7

  BioCryst will host a conference call and webcast at 11:00 a.m. ET to discuss financial results and to provide an update regarding the Company’s clinical development programs.

  October 24, 2017

   · 

  1 min read